THE V ALL-RUSSIAN GMP CONFERENCE TAKES PRIDE IN ITS LONGSTANDING PARTNERSHIP WITH LEADING COMPANIES. ABBOTT COMPANY DEVELOPS NEW PRODUCTS AND TECHNOLOGIES IN SUCH SPHERES AS DIAGNOSTICS, RESEARCH, PRODUCTION OF MINIMALLY INVASIVE MEDICAL DEVICES AND PHARMACEUTICAL PRODUCTS.
ON SEPTEMBER 30, THE AGENDA OF THE 5TH ALL-RUSSIA GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION WILL INCLUDE A ROUNDTABLE DISCUSSION “CONTINUOUS PRODUCTION” INVOLVING A REPORT TO BE DELIVERED BY SOKRAT KIRIDZIS, THE NOVARTIS AREA MANAGER FOR THE DEVELOPMENT AND REGULATORY SUPPORT OF ANTI-CANCER MEDICINES
INFORMATION SUPPORT AS AN ESSENTIAL ELEMENT OF PRESENT-DAY EVENTS TARGETING THE PROFESSIONAL COMMUNITY
LETTER CALENDAR: ON SATURDAY WE PLACE OUR FOCUS ON ROSZDRAVNADZOR’S NEW RECOMMENDATIONS REGARDING THE USE OF THE MDLP SYSTEM BY THE PHARMACEUTICAL INDUSTRY
LETTER CALENDAR: ON SUNDAY LET’S TURN TO THE ISSUE OF IDENTIFYING IMPURITIES IN FINISHED DOSAGE FORMS (FDF)
